Scinai Immunotherapeutics (SCNI) Short Interest Ratio & Short Volume

Short interest is the volume of Scinai Immunotherapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,800 shares of SCNI short. Learn More on Scinai Immunotherapeutics' current short interest.

Scinai Immunotherapeutics saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 1,800 shares, a decline of 84.7% from the previous total of 11,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Scinai Immunotherapeutics: Organovo Holdings, Inc. (0.95%), Aptose Biosciences Inc. (0.76%), Creative Medical Technology Holdings, Inc. (1.38%), BioCardia, Inc. (3.17%), Genetic Technologies Limited (0.53%), Gritstone bio, Inc. (6.83%), Titan Pharmaceuticals, Inc. (1.56%), Palisade Bio, Inc. (3.29%), Avalon GloboCare Corp. (27.35%), TC Biopharm (Holdings) Plc (12.25%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling SCNI is an investing strategy that aims to generate trading profit from Scinai Immunotherapeutics as its price is falling. SCNI shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Scinai Immunotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SCNI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCNI, twice per month. The most recent reporting period available is October, 31 2024.